Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
217.06
-3.51 (-1.59%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Labcorp Holdings Revenue
In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth. Labcorp Holdings had revenue of $3.33B in the quarter ending December 31, 2024, with 9.76% growth.
Revenue (ttm)
$13.01B
Revenue Growth
+6.97%
P/S Ratio
1.40
Revenue / Employee
$185,841
Employees
70,000
Market Cap
18.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
| Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
LH News
- 8 days ago - Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics - GlobeNewsWire
- 9 days ago - Labcorp Declares Quarterly Dividend - PRNewsWire
- 17 days ago - Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - PRNewsWire
- 18 days ago - Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide - PRNewsWire
- 18 days ago - Labcorp to Announce First Quarter Financial Results on April 29, 2025 - PRNewsWire
- 5 weeks ago - Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 7 weeks ago - Labcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors - PRNewsWire
- 2 months ago - Labcorp Holdings: Focus On Core Strengths For Future Growth, Initiate At 'Hold' - Seeking Alpha